FOURTH AMENDMENT TO EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • May 7th, 2019 • Eagle Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This amendment (“Amendment”) is entered into as of April 12, 2019 (the “Fourth Amendment Effective Date”) by and between Eagle Pharmaceuticals, Inc., a Delaware corporation (“Eagle”) and Teva Pharmaceuticals International GmbH, a company formed under Swiss law (“TPIG”). Eagle and TPIG are sometimes referred to herein, individually, as a “Party” or, collectively, as “Parties”.
